FDA approves new alternative painkiller aimed at curbing opioid abuse

July 24, 2014 8:47 PM

20 0

WASHINGTON -- The Food and Drug Administration has approved a new combination pain pill from the maker of OxyContin that is designed to discourage abuse by painkiller addicts.

Purdue Pharma's new drug Targiniq ER is an extended release tablet that combines oxycodone -- the active ingredient in OxyContin -- with the drug naloxone. FDA regulators approved the drug for daily, round-the-clock pain that does not respond to other medications.

Read more

To category page